Gyre Therapeutics Inc.

NASDAQ: GYRE · Real-Time Price · USD
9.37
-0.39 (-4.00%)
At close: May 01, 2025, 3:59 PM
9.34
-0.32%
After-hours: May 01, 2025, 04:20 PM EDT

Gyre Therapeutics Revenue

Gyre Therapeutics reported an annual revenue of $105.76M, reflecting a -6.78% growth. For the quarter ending December 31, 2024, Gyre Therapeutics generated $27.87M in revenue.
Revenue (ttm)
$105.76M
Revenue Growth
-6.78%
Price / Sales Ratio
9.74
Revenue / Employee
$182.65K
Employees
579
Market Cap
878.37M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 105.76M -6.78%
Dec 31, 2023 113.45M +14188.41%
Dec 31, 2022 794K -89.18%
Dec 31, 2021 7.34M -64.97%
Dec 31, 2020 20.95M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.